Roche Holding AG
F:RHO5
Roche Holding AG
F:RHO5
Price:
245.6
EUR
-0.14%
Market Closed
Market Cap:
€209.8B
Relative Value
The Relative Value of one
RHO5
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 245.6 EUR,
Roche Holding AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RHO5 Relative Value
HIDDEN
Multiples Across Competitors
RHO5 Competitors Multiples
Roche Holding AG Competitors
Roche Holding AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Roche Holding AG
F:RHO5
|
257.8B EUR | 4.2 | 20 | 11.8 | 13.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
861.5B USD | 13.4 | 42.2 | 28.5 | 30.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.8B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.5B GBP | 5 | 28.9 | 16 | 22.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
283.5B USD | 4.4 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 103.6 | -82.1 | 380.1 | 953.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 17 | 7.2 | 8.8 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
80.1B GBP | 2.4 | 14 | 7.8 | 9.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
